معرفی
Susan Logue is an Assistant Professor in the Department of Human Anatomy and Cell Science at the Max Rady College of Medicine, University of Manitoba. Her research focuses on the unfolded protein response (UPR), cell signaling, proteostasis, inflammation, and cell death mechanisms in the context of cancer progression. She holds a Tier 2 Canada Research Chair in Cell Stress and Inflammation and has been recognized with the Science Foundation Ireland Starting Investigator Award. Dr. Logue’s work integrates cell biology techniques to study UPR signaling networks and their roles in disease, with affiliations to the Research Institute of Oncology and Hematology (RIOH) and the Children’s Hospital Research Institute of Manitoba (CHRIM).
Education:
- PhD in Biochemistry, National University of Ireland Galway (2021)
- MSc in Laboratory Science, Queen’s University Belfast (2017)
- BSc (Honours) in Biochemistry, Queen’s University Belfast (2015)
Research Focus: Dr. Logue’s lab investigates how the UPR influences cancer cell behavior, including resistance to therapy and metastasis. Her work highlights the interplay between cellular stress responses and inflammatory pathways, with implications for developing novel therapeutic strategies. Key themes include ER stress, apoptosis regulation, and the role of secreted factors in tumor progression.
Awards and Honors:
- Tier 2 Canada Research Chair (2022)
- Science Foundation Ireland Starting Investigator Award (2020)
Advising and Collaborations: Dr. Logue currently mentors Master’s and PhD students, emphasizing translational research in cell stress biology. Her lab collaborates with RIOH and CHRIM to leverage clinical and preclinical resources for impactful discoveries. Active projects explore UPR-driven drug resistance mechanisms and biomarker development for chronic diseases.
Labs and Teams: Affiliated with the University of Manitoba’s Department of Human Anatomy and Cell Science, her lab is a hub for interdisciplinary research into cellular stress pathways, with a focus on oncology and inflammatory disorders.
